Lindsay M. Burt,
MD
Languages Spoken: English
Lindsay Burt, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track assistant professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, Pediatric, and Breast teams.
Dr. Burt’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), accelerated partial breast irradiation (APBI), and high dose rate (HDR) and low dose rate (LDR) brachytherapy.
Dr. Burt earned a bachelor’s degree in Biology-Chemistry at Claremont McKenna College in Claremont, CA. She went on to complete medical school at the University of Utah School of Medicine and residency at the University of Utah Department of Radiation Oncology in Salt Lake City, UT. She is passionate about leadership, promoting education, and research. She served as the Chair of the Association of Residents in Radiation Oncology (ARRO) Executive Committee while she was a resident and was a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) subcommittees and involved in many research projects. She is involved in clinical trials and has completed translational, clinical and database research.
Clinical Locations
Radiation Oncology
801-581-2396
Fax: (801) 585-2666
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Associate Professor (Clinical) |
| Board Certification | American Board of Radiology (Radiation Oncology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.6/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
November 14, 2022
Huntsman Cancer Institute
I always feel comfortable talking with all that have helped me.
UofU Patient
November 12, 2022
Huntsman Cancer Institute
Dr. Burt listens to all my concerns and found answers. She gets back in touch with me, quickly.
UofU Patient
October 06, 2022
HUNTSMAN CANCER CENTER
Both pros and cons of courses of action were explained, as well as estimated recovery time and side effects from treatment. All of my questions were answered, and I feel comfortable about the plan going forward.
UofU Patient
August 03, 2022
HUNTSMAN CANCER CENTER
Dr. Burt was excellent. Both she and Dr. Dood had arrived at pretty much the same conclusions. Both my husband and I were active in the discussion as well in being able to present the type of treatment we though might be best. A treatment was decided upon and it was agreed that it would be conducted closed to home. Dr. Burt, although very profession, took into consider the tension and uncertainty of the patient.
UofU Patient
July 14, 2022
HUNTSMAN CANCER CENTER
Very happy with Dr Burt. Listens and shows that she truly cares for her patients. Attentive and shows that she cares
UofU Patient
July 08, 2022
HUNTSMAN CANCER CENTER
Excellent team to work with
UofU Patient
May 12, 2022
HUNTSMAN CANCER CENTER
Great
UofU Patient
May 08, 2022
HUNTSMAN CANCER CENTER
Dr. Burt is kind and very professional. I am so glad that I have her as my physician.
UofU Patient
April 22, 2022
HUNTSMAN CANCER CENTER
I talked only with Dr. Bert she was excellent in the information she provided, My experience was great!
UofU Patient
April 09, 2022
HUNTSMAN CANCER CENTER
Dr Burt is a fantastic doctor. Took time to show me the pertinent MRI sections and explain them succinctly. My favorite doctor ever! She is a huge credit to the hospital.
UofU Patient
February 11, 2022
HUNTSMAN CANCER CENTER
Dr L Burt is wonderful she is genuinely concerned for my health and comfort. She is happy, friendly and kind. I would absolutely recommend her.
UofU Patient
December 29, 2021
HUNTSMAN CANCER CENTER
Dr. Was very good. Explained all results and went into detail about any changes that may happen in the future and answered my concerns.
UofU Patient
November 19, 2021
HUNTSMAN CANCER CENTER
Good
UofU Patient
August 06, 2021
HUNTSMAN CANCER CENTER
Planned and got excellent results
UofU Patient
June 18, 2021
HUNTSMAN CANCER CENTER
very happy with Dr. Burt and nurse. Dr Burt very caring and helps ease any anxiety or stress. explains everything well and takes time to answer any questions I may have
UofU Patient
June 14, 2021
SUGAR HOUSE HEALTH CENTER
Great staff. Showed a lot of concern and answered all our questions. Made us all feelrelaxed and comfortable.
UofU Patient
May 09, 2021
HUNTSMAN CANCER CENTER
Dr. Burt is very straight forward and I like her approach.
UofU Patient
May 02, 2021
HUNTSMAN CANCER CENTER
The 2 doctors we talked with were both caring and professional.
UofU Patient
April 23, 2021
HUNTSMAN CANCER CENTER
dr Lindsay Burt was excellent
Lindsay Burt, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track assistant professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, Pediatric, and Breast teams.
Dr. Burt’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), accelerated partial breast irradiation (APBI), and high dose rate (HDR) and low dose rate (LDR) brachytherapy.
Dr. Burt earned a bachelor’s degree in Biology-Chemistry at Claremont McKenna College in Claremont, CA. She went on to complete medical school at the University of Utah School of Medicine and residency at the University of Utah Department of Radiation Oncology in Salt Lake City, UT. She is passionate about leadership, promoting education, and research. She served as the Chair of the Association of Residents in Radiation Oncology (ARRO) Executive Committee while she was a resident and was a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) subcommittees and involved in many research projects. She is involved in clinical trials and has completed translational, clinical and database research.
Academic Locations
Huntsman Cancer Hospital
801-581-2396
(801) 585-2666
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Associate Professor (Clinical) |
| Board Certification | American Board of Radiology (Radiation Oncology) |
Education History
| Certification | University of Utah Quality Improvement Certification, 2019 |
| Certification | University of Utah David Ecceles School of Business Health Science Leadership Program Certification, 2018 |
| Residency | University of Utah, Huntsman Cancer Hospital Radiation Oncology Resident, 2016 |
| Chief Resident | University of Utah, Huntsman Cancer Hospital Radiation Oncology Chief Resident, 2015 |
| Internship | Sacred Heart Medical Center Transitional Year Transitional Internship, 2012 |
| Professional Medical | University of Utah School of Medicine Medicine M.D., 2011 |
| Undergraduate | Claremont McKenna College Biology-Chemistry B.A., 2007 |
| Undergraduate | Boise State University, Honors College , 2004 |
| Undergraduate | Willamette University Chemical Engineering with Biomedical specialization , 2003 |
Selected Publications - Journal Articles
Journal Article
- Kundu B, Brock AA, Garry JG, Jensen RL, Burt LM, Cannon DM, Shrieve DC, Rolston JD (2022). Outcomes using linear accelerator stereotactic radiosurgery for the treatment of trigeminal neuralgia: A single-center, retrospective study. Surg Neurol Int, 13, 246.
- Kraus RD, Weil CR, Frances Su FC, Cannon DM, Burt LM, Mendez JS (2022). Incidence and extent of disease progression on MRI between surgery and initiation of radiotherapy in glioblastoma patients. Neurooncol Pract, 9(5), 380-389.
- Peterson JS, Peckham ME, Poppe MM, Burt LM, Shrieve DC, Cannon DM (2022). Delineating the Subarachnoid Space in the Adult Lumbosacral Spine Using Computed Tomographic Myelography: An Aid for Clinical Target Volume Delineation in Craniospinal Irradiation. Adv Radiat Oncol, 7(5), 100994.
- Weil CR, Lew FH, Williams VM, Burt LM, Ermoian RP, Poppe MM (2022). Patterns of Care and Utilization Disparities in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. Adv Radiat Oncol, 7(6), 100868.
- Hutten RJ, Fenlon JB, Kessel AC, Straessler KM, Huang YJ, Gaffney DK, Suneja G, Zempolich K, Burt LM (2022). Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma. Brachytherapy.
- Hsieh K, Housri N, Haffty B, Smith B, Burt LM (2021). Radiation Oncologists' Views on Breast Radiation Therapy Guidelines: Utilizing an Online Q&A Platform to Assess Current Views on Whole-Breast Irradiation Therapy. Clin Breast Cancer, 21(5), 408-416.
- Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, Scott AA, Anorlu RI, Sharma V, Plante M, Nyongesa C, Tigeneh W, Fakie N, Suneja G, Gaffney DK (2021). Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management. JCO Glob Oncol, 7, 173-182.
- Wei M, Wang X, Zimmerman DN, Burt LM, Haaland B, Henry NL (2021). Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer. Breast Cancer Res Treat, 187(1), 287-294.
- Parsons MW, Whipple NS, Poppe MM, Mendez JS, Cannon DM, Burt LM (2020). The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma. J Neurooncol, 151(2), 93-101.
- Bejjani A, Burt L, Washington C, Terao M, Housri S, Housri N (2020). Using a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic. JCO Clin Cancer Inform, 4, 794-798.
- Cohen AL, Anker CJ, Johnson B, Burt LM, Shrieve DC, Salzman K, Jensen R, Boucher K, Colman H (2020). Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial. J Neurooncol, 148(3), 577-585.
- McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2019). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92.
- Ager BJ, Torgeson A, Francis SR, Burt LM, Gaffney DK, Cannon DM (2019). Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation. Am J Clin Oncol, 43(1), 35-42.
- Ager BJ, Christensen MT, Burt LM, Poppe MM (2019). The value of high-dose radiotherapy in intracranial ependymoma. Pediatr Blood Cancer, 66(6), e27697.
- Park J, Blackburn BE, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Burt L, Werner T, Gaffney DK, Lopez AM, Mooney K, Hashibe M (2018). Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol, 28(6), 377-384.
- Burt LM, Shrieve DC, Tward JD (2018). Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database. Adv Radiat Oncol, 3(2), 170-180.
- Burt LM, Ying J, Poppe MM, Suneja G, Gaffney DK (2017). Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast, 35, 122-129.
- Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve DC (2017). Adjuvant radiotherapy for atypical meningiomas. J Neurosurg, 126(6), 1822-1828.
- Burt LM, Trifiletti DM, Nabavizadeh N, Katz LM, Morris ZS, Royce TJ (2017). Supply and Demand for Radiation Oncology in the United States: A Resident Perspective. Int J Radiat Oncol Biol Phys, 97(2), 225-227.
- Gonzalez VJ, Hullett CR, Burt L, Rassiah-Szegedi P, Sarkar V, Tward JD, Hazard LJ, Huang YJ, Salter BJ, Gaffney DK (2017). Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy. Adv Radiat Oncol, 2(2), 235-243.
- Mattes MD, Patel KR, Burt LM, Hirsch AE (2016). A Nationwide Medical Student Assessment of Oncology Education. J Cancer Educ, 31(4), 679-686.
- Verma V, Burt L, Gimotty PA, Ojerholm E (2016). Contemporary Trends in Radiation Oncology Resident Research. Int J Radiat Oncol Biol Phys, 96(4), 915-918.
- Burt LM, Poppe MM, Kokeny KE, Gaffney DK, Shrieve DC, Tward JD (2016). Comparison of Treatments for Breast Cancer Arising after Radiation Treatment for Hodgkin’s Lymphoma. J Radiat Oncol, 6(1), 65-72.
- Burt LM, Orlandi RR, Hunt JP, Buchmann LO, Grossmann KF, Monroe MM, Shrieve DC, Hitchcock Y (2016). Function Preservation and Optimal Outcomes – Definitive Chemoradiotherapy with Multi-phase Treatment Planning for Locally Advanced Sinonasal Cancer. J Radiat Oncol, 5(1), 47-54.
- Nabavizadeh N, Burt LM, Mancini BR, Morris ZS, Walker AJ, Miller SM, Bhavsar S, Mohindra P, Kim MB, Kharofa J (2016). Results of the 2013-2015 Association of Residents in Radiation Oncology Survey of Chief Residents in the United States. Int J Radiat Oncol Biol Phys, 94(2), 228-34.
- Karsy M, Hoang N, Barth T, Burt L, Dunson W, Gillespie DL, Jensen RL (2016). Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies. World Neurosurg, 86, 210-9.
- Burt LM, Shrieve DC, Tward JD (2014). Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys, 88(1), 94-100.
- Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR (2012). Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study. J Cutan Pathol, 39(2), 243-50.
- Harris K, Vanderhooft L, Burt L, Vanderhooft S, Hull C (2012). Tanning business practices in Salt Lake County, Utah. J Am Acad Dermatol, 66(3), 513-514.
Review
- Parsons MW, Huang YJ, Burt L, Suneja G, Gaffney D (2021). Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation. [Review]. Int J Gynecol Cancer, 32(3), 311-315.
- Tao R, Lloyd S, Burt L, Whisenant J, Garrido-Laguna I, Das P (2017). Pelvic Reirradiation for the Treatment of Locally Recurrent Rectal Cancer. [Review]. Curr Colorectal Cancer Rep, 13(2), 175-182.
Book Chapter
- Burt LM, Suneja G, Shrieve DC (2018). Pituitary adenoma. In Burt LM|Suneja G|Shrieve DC (Ed.), Adult CNS Radiation Oncology: Principles and Practice (pp. 19-35).
- Burt LM, Suneja G, Shrieve DC (2018). Pituitary Tumors. In Chang E, Brown P, Lo S, Sahgal A, Suh J (Eds.), Adult CNS Radiation Oncology (1st). Springer.